Actively Recruiting

Age: 18Years +
All Genders
NCT07470593

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Led by University Hospital, Strasbourg, France · Updated on 2026-03-17

36

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Islet transplantation is associated with drastically improvement glucose control in people with type 1 diabetes. This treatment resulted in the disappearance of severe hypoglycemic events. However, its long-term effectiveness is limited by progressive loss of graft function. Currently, there is no standardized method to detect early dysfunction of the transplanted islets. This study aims to determine whether a parameter derived from continuous glucose monitoring (CGM), Time in Tight Range (70-140 mg/dL), is associated with pancreatic islet grafts function. The study hypothesis is that a decrease in Time in Tight Range reflects early loss of islet graft function.

CONDITIONS

Official Title

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years old or older
  • Have insulin-dependent diabetes (type 1 diabetes or diabetes secondary to chronic pancreatitis, MODY, cystic fibrosis)
  • Completed a full cycle of pancreatic islet transplantation: Islet Transplantation Alone, Islet After Kidney, or Simultaneous Islet Kidney
  • Received more than 10,000 IEQ/kg of body weight, or less than 10,000 IEQ/kg but achieved insulin independence
  • Provided consent for reuse of their data for this research
Not Eligible

You will not qualify if you...

  • Refusal to wear a continuous glucose monitoring device
  • Pancreatic islet autotransplantation
  • Unable to provide informed consent (difficulty understanding study information)
  • Under judicial protection (safeguard of justice)
  • Under guardianship or curatorship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hopitaux Universitaires de Strasbourg

Strasbourg, France, 67200

Actively Recruiting

Loading map...

Research Team

P

Pargol ZANDYAZDI

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function. | DecenTrialz